Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 6797851, 11 pages
http://dx.doi.org/10.1155/2016/6797851
Research Article

In Vivo Effects of Vanadium Pentoxide and Antioxidants (Ascorbic Acid and Alpha-Tocopherol) on Apoptotic, Cytotoxic, and Genotoxic Damage in Peripheral Blood of Mice

Unidad de Investigación en Genética y Toxicología Ambiental (UNIGEN), Facultad de Estudios Superiores “Zaragoza”, Universidad Nacional Autónoma de México (UNAM), P.O. Box 9-020, 15000 México, DF, Mexico

Received 1 January 2016; Revised 11 April 2016; Accepted 16 May 2016

Academic Editor: Tim Hofer

Copyright © 2016 María del Carmen García-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Evangelou, “Vanadium in cancer treatment,” Critical Reviews in Oncology/Hematology, vol. 42, no. 3, pp. 249–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Mukherjee, B. Patra, S. Mahapatra, P. Banerjee, A. Tiwari, and M. Chatterjee, “Vanadium—an element of atypical biological significance,” Toxicology Letters, vol. 150, no. 2, pp. 135–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. International Agency for Research on Cancer (IARC), Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, vol. 86 of IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (IARC), Lyon, France, 2006.
  4. American Conference of Governmental Industrial Hygienists (ACGIH), “Vanadium pentoxide: chemical substances 7th edition documentation, 9,” in Appendix B: Threshold Limit Values (TLVs®) and Biological Exposure Indices (BEIs®), 2012, http://www.nsc.org/facultyportal/Documents/fih-6e-appendix-b.pdf. View at Google Scholar
  5. T. B. Starr, J. A. MacGregor, K. D. Ehman, and A. I. Nikiforov, “Vanadium pentoxide: use of relevant historical control data shows no evidence for a carcinogenic response in F344/N rats,” Regulatory Toxicology and Pharmacology, vol. 64, no. 1, pp. 155–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. L. Assem and L. S. Levy, “A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research,” Journal of Toxicology and Environmental Health, Part B: Critical Reviews, vol. 12, no. 4, pp. 289–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. L. Assem and A. Oskarsson, “Vanadium,” in Handbook on the Toxicology of Metals, pp. 1347–1367, 4th edition, 2015. View at Google Scholar
  8. L. A. Soriano-Agueda, C. Ortega-Moo, J. Garza, J. A. Guevara-García, and R. Vargas, “Formation of reactive oxygen species by vanadium complexes,” Computational and Theoretical Chemistry, vol. 1077, pp. 99–105, 2016. View at Publisher · View at Google Scholar
  9. J. B. Mailhes, C. Hilliard, J. W. Fuseler, and S. N. London, “Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells,” Mutation Research, vol. 538, no. 1-2, pp. 101–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Shi and N. S. Dalal, “Hydroxyl radical generation in the NADH/microsomal reduction of vanadate,” Free Radical Research, vol. 17, no. 6, pp. 369–376, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. W. F. Costa and J. C. Nepomuceno, “Protective effects of a mixture of antioxidant vitamins and minerals on the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster,” Environmental and Molecular Mutagenesis, vol. 47, no. 1, pp. 18–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. C. García-Rodríguez, M. M. Carvente-Juárez, and M. A. Altamirano-Lozano, “Antigenotoxic and apoptotic activity of green tea polyphenol extracts on hexavalent chromium-induced DNA damage in peripheral blood of CD-1 mice: analysis with differential acridine orange/ethidium bromide staining,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 486419, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. M. Antunes and C. S. Takahashi, “Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells,” Mutation Research, vol. 419, no. 1–3, pp. 137–143, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. H. Siddique, T. Beg, and M. Afzal, “Antigenotoxic effects of ascorbic acid against megestrol acetate-induced genotoxicity in mice,” Human and Experimental Toxicology, vol. 24, no. 3, pp. 121–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Singh, P. Kaur, R. Sandhir, and R. Kiran, “Protective effects of vitamin E against atrazine-induced genotoxicity in rats,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 654, no. 2, pp. 145–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Cameron and L. Pauling, Cancer and Vitamin C, W.W. Norton & Company, Inc, New York, NY, USA, 1979.
  17. G. Block, “Vitamin C and cancer prevention: the epidemiologic evidence,” The American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 270S–282S, 1991. View at Google Scholar · View at Scopus
  18. B. Frei, “Reactive oxygen species and antioxidant vitamins: mechanisms of action,” The American Journal of Medicine, vol. 97, no. 3, pp. 5S–13S, 1994. View at Google Scholar · View at Scopus
  19. K. A. Naidu, “Vitamin C in human health and disease is still a mystery? An overview,” Nutrition Journal, vol. 2, article 7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sugiyama, K. Tsuzuki, K. Matsumoto, and R. Ogura, “Effect of vitamin E on cytotoxicity, DNA single strand breaks, chromosomal aberrations, and mutation in Chinese hamster V-79 cells exposed to ultraviolet-B light,” Photochemistry and Photobiology, vol. 56, no. 1, pp. 31–34, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lunec, E. Halligan, N. Mistry, and K. Karakoula, “Effect of vitamin E on gene expression changes in diet-related carcinogenesis,” Annals of the New York Academy of Sciences, vol. 1031, pp. 169–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Packer, “Protective role of vitamin E in biological systems,” American Journal of Clinical Nutrition, vol. 53, no. 4, pp. 1050S–1055S, 1991. View at Google Scholar · View at Scopus
  23. H. J. Kayden and M. G. Traber, “Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans,” Journal of Lipid Research, vol. 34, no. 3, pp. 343–358, 1993. View at Google Scholar · View at Scopus
  24. A. Ogutcu, M. Uzunhisarcikli, S. Kalender, D. Durak, F. Bayrakdar, and Y. Kalender, “The effects of organophosphate insecticide diazinon on malondialdehyde levels and myocardial cells in rat heart tissue and protective role of vitamin E,” Pesticide Biochemistry and Physiology, vol. 86, no. 2, pp. 93–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. L. Haber and R. W. Wissler, “Effect of vitamin E on carcinogenicity of methylcholanthrene.,” Experimental Biology and Medicine, vol. 111, no. 3, pp. 774–775, 1962. View at Publisher · View at Google Scholar
  26. M. García-Rodríguez, G. Serrano-Reyes, and M. Altamirano-Lozano, “Comparative study in vivo of the genotoxic damage induced by CrO3 and the effects of the antioxidants: ascorbic acid, alfa-tocopherol and beta-carotene,” Free Radical Biology and Medicine, vol. 53, no. 1, article S216, 2012. View at Publisher · View at Google Scholar
  27. M. A. Altamirano-Lozano, A. R. Montaño-Rodríguez, G. P. García-Cárdenas, P. Peralta-García, and M. C. García-Rodríguez, “Estudio de las frecuencias de micronúcleos en sangre periférica de ratón CD-1 tratados con trióxido de cromo, sulfato de talio y pentóxido de vanadio in vivo,” Revista Internacional de Contaminación Ambiental, vol. 29, no. 4, p. 154, 2013. View at Google Scholar
  28. J. A. Heddle, M. Hite, B. Kirkhart et al., “The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program,” Mutation Research, vol. 123, no. 1, pp. 61–118, 1983. View at Publisher · View at Google Scholar · View at Scopus
  29. CSGMT (The Collaborative Study Group for the Micronucleus Test), “Protocol recommended by the CSGMT/JEMS.MMS for the short-term mouse peripheral blood micronucleus test. The Collaborative Study Group for the Micronucleus Test (CSGMT) (CSGMT/JEMS.MMS, The Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan),” Mutagenesis, vol. 10, no. 3, pp. 153–159, 1995. View at Google Scholar
  30. M. Hayashi, T. Morita, Y. Kodama, T. Sofuni, and M. Ishidate Jr., “The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides,” Mutation Research Letters, vol. 245, no. 4, pp. 245–249, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. M. C. García-Rodríguez, V. López-Santiago, and M. Altamirano-Lozano, “Effect of chlorophyllin on chromium trioxide-induced micronuclei in polychromatic erythrocytes in mouse peripheral blood,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 496, no. 1-2, pp. 145–151, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. A. J. McGahon, S. J. Martin, R. P. Bissonnette et al., “The end of the (cell) line: methods for the study of apoptosis in vitro,” in Methods in Cell Biology, vol. 46, chapter 9, pp. 153–185, 1995. View at Publisher · View at Google Scholar
  33. NTP, “Toxicology and carcinogenesis studies of vanadium pentoxide,” NTP TR 507, National Toxicology Program, Research Triangle Park, NC, USA, 2002. View at Google Scholar
  34. R. Ciranni, M. Antonetti, and L. Migliore, “Vanadium salts induce cytogenetic effects in in vivo treated mice,” Mutation Research, vol. 343, no. 1, pp. 53–60, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Leopardi, P. Villani, E. Cordelli, E. Siniscalchi, E. Veschetti, and R. Crebelli, “Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure,” Toxicology Letters, vol. 158, no. 1, pp. 39–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Rojas-Lemus, M. Altamirano-Lozano, and T. I. Fortoul, “Sex differences in blood genotoxic and cytotoxic effects as a consequence of vanadium inhalation: micronucleus assay evaluation,” Journal of Applied Toxicology, vol. 34, no. 3, pp. 258–264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. García-Rodríguez, G. P. García-Cárdenas, A. R. Montaño-Rodríguez, and M. A. Altamirano-Lozano, “Cytotoxic and genotoxic effects of exposure to heavy metals (chromium [VI] and thallium [I]) of mice CD-1 strain: micronucleus, apoptosis and cell viability,” Acta Universitaria, vol. 24, no. 2, pp. 91–96, 2014. View at Google Scholar
  38. EPA. Environmental Protection Agency, “Toxicological review of hexavalent chromium,” in Support of Summary Information on the Integrated Risk information System (IRIS), Office of Research and Development, Washington, DC, USA, 2010. View at Google Scholar
  39. D. J. Tweats, D. Blakey, R. H. Heflich et al., “Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 627, no. 1, pp. 78–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Krishna and M. Hayashi, “In vivo rodent micronucleus assay: protocol, conduct and data interpretation,” Mutation Research, vol. 455, no. 1-2, pp. 155–166, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. G. R. Hogan, “Peripheral erythrocyte levels, hemolysis and three vanadium compounds,” Experientia, vol. 46, no. 5, pp. 444–446, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. M. V. Aguirre, J. A. Juaristi, M. A. Alvarez, and N. C. Brandan, “Characteristics of in vivo murine erythropoietic response to sodium orthovanadate,” Chemico-Biological Interactions, vol. 156, no. 1, pp. 55–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. N. H. Kleinsasser, P. Dirschedl, R. Staudenmaier, U. A. Harréus, and B. C. Wallner, “Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract,” International Journal of Environmental Health Research, vol. 13, no. 4, pp. 373–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. F. C. R. Manning and S. R. Patierno, “Apoptosis: inhibitor or instigator of carcinogenesis?” Cancer Investigation, vol. 14, no. 5, pp. 455–465, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Assimakopoulos, E. Kolettas, N. Zagorianakou, A. Evangelou, A. Skevas, and N. J. Agnantis, “Prognostic significance of p53 in the cancer of the larynx,” Anticancer Research, vol. 20, no. 5, pp. 3555–3564, 2000. View at Google Scholar · View at Scopus
  46. J. Whitwell, R. Smith, K. Jenner et al., “Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: implications for improving existing assays,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 789-790, pp. 7–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. T. I. Fortoul, V. Rodriguez-Lara, A. González-Villalva et al., “Inhalation of vanadium pentoxide and its toxic effects in a mouse model,” Inorganica Chimica Acta, vol. 420, pp. 8–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Huang, Z. Zhang, M. Ding et al., “Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis,” The Journal of Biological Chemistry, vol. 275, no. 42, pp. 32516–32522, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. J. W. Crott and M. Fenech, “Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo,” Carcinogenesis, vol. 20, no. 6, pp. 1035–1041, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. A. C. Mamede, S. D. Tavares, A. M. Abrantes, J. Trindade, J. M. Maia, and M. F. Botelho, “The role of vitamins in cancer: a review,” Nutrition and Cancer, vol. 63, no. 4, pp. 479–494, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Shi, H. Jiang, Y. Mao, J. Ye, and U. Saffiotti, “Vanadium(IV)-mediated free radical generation and related 2′-deoxyguanosine hydroxylation and DNA damage,” Toxicology, vol. 106, no. 1–3, pp. 27–38, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. M. C. Putchala, P. Ramani, H. J. Sherlin, P. Premkumar, and A. Natesan, “Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity—a systematic review,” Archives of Oral Biology, vol. 58, no. 6, pp. 563–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. D. C. Crans, B. Baruah, E. Gaidamauskas, B. G. Lemons, B. B. Lorenz, and M. D. Johnson, “Impairment of ascorbic acid's anti-oxidant properties in confined media: inter and intramolecular reactions with air and vanadate at acidic pH,” Journal of Inorganic Biochemistry, vol. 102, no. 5-6, pp. 1334–1347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. D. C. Horton, D. VanDerveer, J. Krzystek et al., “Spectroscopic characterization of L-ascorbic acid-induced reduction of vanadium(V) dipicolinates: formation of vanadium(III) and vanadium(IV) complexes from vanadium(V) dipicolinate derivatives,” Inorganica Chimica Acta, vol. 420, pp. 112–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. M. C. García-Rodríguez, R. E. Vilches-Larrea, T. Nicolás-Mendez, and M. A. Altamirano-Lozano, “Green tea and its role on chemoprevention in vivo of genotoxic damage induced by carcinogenic metals (chromium [VI]),” Nutricion Hospitalaria, vol. 27, no. 4, pp. 1204–1212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. M. D. C. García-Rodríguez, R. A. Mateos-Nava, and M. Altamirano-Lozano, “In vivo effect of red wine undiluted, diluted (75%) and alcohol-free on the genotoxic damage induced by potential carcinogenic metals: chromium [VI],” Nutrición Hospitalaria, vol. 32, no. 4, pp. 1645–1652, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. M. D. C. García-Rodríguez, T. Nicolás-Méndez, A. R. Montaño-Rodríguez, and M. A. Altamirano-Lozano, “Antigenotoxic effects of (−)-epigallocatechin-3-gallate (EGCG), quercetin, and rutin on chromium trioxide-induced micronuclei in the polychromatic erythrocytes of mouse peripheral blood,” Journal of Toxicology and Environmental Health Part A, vol. 77, no. 6, pp. 324–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Raff, “Cell suicide for beginners,” Nature, vol. 396, no. 6707, pp. 119–122, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. P. W. Sylvester, “Vitamin E and apoptosis,” Vitamins and Hormones, vol. 76, pp. 329–356, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Gao, W. Li, L. Jia, B. Li, Y. C. Chen, and Y. Tu, “Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways,” Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 370–374, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. M. C. García-Rodríguez, A. R. Montaño-Rodríguez, and M. A. Altamirano-Lozano, “Modulation of hexavalent chromium-induced genotoxic damage in peripheral blood of mice by epigallocatechin-3-gallate (EGCG) and its relationship to the apoptotic activity,” Journal of Toxicology and Environmental Health, Part A: Current Issues, vol. 79, no. 1, pp. 28–38, 2016. View at Publisher · View at Google Scholar
  63. E. Kioseoglou, S. Petanidis, C. Gabriel, and A. Salifoglou, “The chemistry and biology of vanadium compounds in cancer therapeutics,” Coordination Chemistry Reviews, vol. 301-302, pp. 87–105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. J. C. Pessoa, S. Etcheverry, and D. Gambino, “Vanadium compounds in medicine,” Coordination Chemistry Reviews, vol. 301-302, pp. 24–48, 2015. View at Publisher · View at Google Scholar · View at Scopus